Marcolongo R, Frati E, Biasi G, Franci A, Fioravanti A
Clin Ter. 1989 Feb 15;128(3):165-71.
Twenty patients suffering from acute lumbosacral syndromes (Group A) and eight patients suffering from acute gout (Group B) were treated with parenteral tiaprofenic acid (TA). In Group A TA was administered for 7 days at the dosage of 400 mg/daily for the first four days (1 200 mg vial i.m. in the morning, 1 in the evening), from the 5th to the 7th day with 200 mg/daily (1 vial in the evening) and, in Group B, TA was administered for 6 days at the dosage of 600 mg on the first day, (with 1 vial/8 hours of TA 200 mg by parenteral route) the 2nd and 3rd day with 1 vial/12 hours and the 4th and 6th day with 1 vial/daily in the evening. TA was found to be active on all clinical parameters evaluated. The tolerability was also good: only 4 patients with acute lumbosacral syndrome suffered from local pain.
20例急性腰骶部综合征患者(A组)和8例急性痛风患者(B组)接受了胃肠外给予噻洛芬酸(TA)的治疗。在A组中,TA给药7天,前4天剂量为每日400mg(上午1瓶200mg的TA肌内注射,晚上1瓶),第5至7天剂量为每日200mg(晚上1瓶);在B组中,TA给药6天,第一天剂量为600mg(每8小时胃肠外给予1瓶200mg的TA),第2和3天每12小时1瓶,第4和6天晚上每日1瓶。结果发现TA对所有评估的临床参数均有作用。耐受性也良好:仅4例急性腰骶部综合征患者出现局部疼痛。